0.8766
price down icon3.34%   -0.0303
 
loading
前日終値:
$0.9069
開ける:
$0.89
24時間の取引高:
570.16K
Relative Volume:
0.87
時価総額:
$78.32M
収益:
-
当期純損益:
$-166.14M
株価収益率:
-0.4542
EPS:
-1.93
ネットキャッシュフロー:
$-139.92M
1週間 パフォーマンス:
-24.43%
1か月 パフォーマンス:
-34.58%
6か月 パフォーマンス:
-35.54%
1年 パフォーマンス:
-49.03%
1日の値動き範囲:
Value
$0.7962
$0.929
1週間の範囲:
Value
$0.7962
$1.17
52週間の値動き範囲:
Value
$0.535
$3.405

Allakos Inc Stock (ALLK) Company Profile

Name
名前
Allakos Inc
Name
セクター
Healthcare (1195)
Name
電話
650-597-5002
Name
住所
825 INDUSTRIAL ROAD, SAN CARLOS, CA
Name
職員
131
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
ALLK's Discussions on Twitter

ALLK を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ALLK 0.8766 78.32M 0 -166.14M -139.92M -1.93
VRTX 450.97 116.14B 10.63B -479.80M -1.35B 13.33
REGN 738.00 81.10B 13.85B 4.65B 3.32B 35.06
ARGX 605.92 36.23B 1.86B -40.29M -1.28B -4.16
ALNY 244.89 31.59B 2.09B -332.26M 16.06M -4.14
BNTX 113.13 27.12B 3.30B -501.07M 1.03B 11.54

Allakos Inc Stock (ALLK) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-01-17 ダウングレード Jefferies Buy → Hold
2024-01-16 ダウングレード Cantor Fitzgerald Overweight → Neutral
2023-12-18 アップグレード William Blair Mkt Perform → Outperform
2023-12-08 再開されました Jefferies Buy
2023-09-27 開始されました JMP Securities Mkt Outperform
2023-05-12 アップグレード Jefferies Hold → Buy
2023-03-07 開始されました Piper Sandler Overweight
2022-09-12 ダウングレード SMBC Nikko Neutral → Underperform
2021-12-22 ダウングレード BofA Securities Buy → Underperform
2021-12-22 ダウングレード Cowen Outperform → Market Perform
2021-12-22 ダウングレード Jefferies Buy → Hold
2021-12-22 ダウングレード SVB Leerink Outperform → Mkt Perform
2021-12-22 ダウングレード William Blair Outperform → Mkt Perform
2021-08-26 開始されました Morgan Stanley Equal-Weight
2021-07-15 開始されました Cowen Outperform
2021-05-18 開始されました H.C. Wainwright Buy
2021-02-24 開始されました Cantor Fitzgerald Overweight
2021-01-15 開始されました BofA Securities Buy
2020-12-21 開始されました SVB Leerink Outperform
2020-02-27 開始されました Barclays Underweight
2020-02-04 再開されました Goldman Neutral
2018-08-13 開始されました Goldman Neutral
2018-08-13 開始されました Jefferies Buy
2018-08-13 開始されました William Blair Outperform
すべてを表示

Allakos Inc (ALLK) 最新ニュース

pulisher
Nov 20, 2024

Allakos Reports Q3 2024 Results and Research Progress - TipRanks

Nov 20, 2024
pulisher
Nov 20, 2024

All You Need to Know About Allakos (ALLK) Rating Upgrade to Buy - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Allakos Inc. finalizes early lease termination, incurring $2.5 million in costs - Investing.com Canada

Nov 19, 2024
pulisher
Nov 18, 2024

Allakos Inc. Alters Lease Agreement for Cost Savings - TipRanks

Nov 18, 2024
pulisher
Nov 13, 2024

FMR LLC's Strategic Acquisition of Allakos Inc Shares - GuruFocus.com

Nov 13, 2024
pulisher
Nov 12, 2024

Allakos's SWOT analysis: biotech firm's stock faces hurdles in CSU market - Investing.com

Nov 12, 2024
pulisher
Nov 11, 2024

FY2024 EPS Estimates for Allakos Raised by Leerink Partnrs - MarketBeat

Nov 11, 2024
pulisher
Nov 07, 2024

Allakos Runs Up Into A Near-Term Catalyst (NASDAQ:ALLK) - Seeking Alpha

Nov 07, 2024
pulisher
Nov 06, 2024

Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 06, 2024
pulisher
Nov 04, 2024

Allakos perks up after early-stage data for lead asset - MSN

Nov 04, 2024
pulisher
Nov 04, 2024

Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.

Nov 04, 2024
pulisher
Oct 28, 2024

Allakos Inc. (NASDAQ:ALLK) Short Interest Down 17.1% in October - MarketBeat

Oct 28, 2024
pulisher
Oct 22, 2024

3 US Penny Stocks With Market Caps Larger Than $50M - Simply Wall St

Oct 22, 2024
pulisher
Oct 22, 2024

Allakos Insiders Miss 24% Gain After Offloading Stock - Simply Wall St

Oct 22, 2024
pulisher
Oct 21, 2024

Vernal Keratoconjunctivitis Market Growth to Accelerate - openPR

Oct 21, 2024
pulisher
Oct 17, 2024

The Manufacturers Life Insurance Company Sells 2,148 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World

Oct 17, 2024
pulisher
Oct 17, 2024

Short Interest in Custom Truck One Source, Inc. (NYSE:CTOS) Decreases By 5.5% - Defense World

Oct 17, 2024
pulisher
Oct 16, 2024

Nasal Polyposis Market Size is Set for Rapid Growth as Innovative - openPR

Oct 16, 2024
pulisher
Oct 15, 2024

Chronic Spontaneous Urticaria Market Forecasted to Surge - openPR

Oct 15, 2024
pulisher
Oct 14, 2024

Jefferies downgrades Allakos Inc (ALLK) stock to a Hold - Knox Daily

Oct 14, 2024
pulisher
Oct 14, 2024

Allakos Inc (ALLK)’s stock price range in the last year - US Post News

Oct 14, 2024
pulisher
Oct 14, 2024

Investor’s Delight: Allakos Inc (ALLK) Closes Weak at 0.65, Down -1.14 - The Dwinnex

Oct 14, 2024
pulisher
Oct 12, 2024

Allakos shares hold rating after trial update By Investing.com - Investing.com Australia

Oct 12, 2024
pulisher
Oct 12, 2024

Piper Sandler maintains Overweight rating on Allakos shares By Investing.com - Investing.com Australia

Oct 12, 2024
pulisher
Oct 11, 2024

TD Cowen Reiterates Hold Rating on Allakos Inc. (ALLK) - StreetInsider.com

Oct 11, 2024
pulisher
Oct 11, 2024

Piper Sandler maintains Overweight rating on Allakos shares - Investing.com India

Oct 11, 2024
pulisher
Oct 11, 2024

Allakos shares hold rating after trial update - Investing.com

Oct 11, 2024
pulisher
Oct 11, 2024

Allakos stock gains on trial data for lead drug (NASDAQ:ALLK) - Seeking Alpha

Oct 11, 2024
pulisher
Oct 11, 2024

Piper Sandler Reiterates Overweight Rating on Allakos Inc. (ALLK) - StreetInsider.com

Oct 11, 2024
pulisher
Oct 10, 2024

Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers - ForexTV.com

Oct 10, 2024
pulisher
Oct 10, 2024

Allakos reports positive results from AK006 Phase 1 study - Investing.com India

Oct 10, 2024
pulisher
Oct 10, 2024

Allakos Progress Update on AK006 and Future Milestones - TipRanks

Oct 10, 2024
pulisher
Oct 10, 2024

Allakos reports positive results from AK006 Phase 1 study By Investing.com - Investing.com UK

Oct 10, 2024
pulisher
Oct 10, 2024

Allakos (ALLK) Reports Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers - StreetInsider.com

Oct 10, 2024
pulisher
Oct 08, 2024

SG Americas Securities LLC Grows Stake in Stellantis (NYSE:STLA) - Defense World

Oct 08, 2024
pulisher
Sep 30, 2024

Vernal Keratoconjunctivitis Market to Show Remarkable Growth - openPR

Sep 30, 2024
pulisher
Sep 30, 2024

Vernal Keratoconjunctivitis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Santen SAS, Novartis, Laboratoires Thea, Allakos Inc., Santen SASl, Astellas Pharma Inc - Barchart

Sep 30, 2024
pulisher
Sep 29, 2024

Duff & Phelps Investment Management Co. Cuts Holdings in Enbridge Inc. (NYSE:ENB) - Defense World

Sep 29, 2024
pulisher
Sep 28, 2024

Allakos (ALLK): Strong Industry, Solid Earnings Estimate Revisions - MSN

Sep 28, 2024
pulisher
Sep 27, 2024

Wall Street SWOT: Allakos stock faces pivotal year as AK006 data looms - Investing.com

Sep 27, 2024
pulisher
Sep 26, 2024

Allakos (NASDAQ:ALLK) Receives Market Outperform Rating from JMP Securities - MarketBeat

Sep 26, 2024
pulisher
Sep 23, 2024

Leerink Partners analysts initates a Market perform rating for Align Technology, Inc. (ALGN) - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Defense Stock Soars on ‘Rare Move’ From the U.S. Army - Barron's

Sep 23, 2024
pulisher
Sep 23, 2024

French InsurTech Alan raises $193m to bolster tech and growth in Belgium - FinTech Global

Sep 23, 2024
pulisher
Sep 23, 2024

Allied Properties Real Estate Investment Trust (TSE:AP.UN) Price Target Increased to C$18.50 by Analysts at Canaccord Genuity Group - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Aligos Therapeutics (NASDAQ:ALGS) Reaches New 52-Week Low at $8.28 - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Allogene Therapeutics Inc [ALLO] Stock bought by Insider Douglas Earl Martin for $78844.0 - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Alignment Healthcare (NASDAQ:ALHC) Shares Gap Down to $11.43 - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Investing in Alta Equipment Group Inc (ALTG): What You Must Know - Knox Daily

Sep 23, 2024

Allakos Inc (ALLK) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
大文字化:     |  ボリューム (24 時間):